Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

VOLUME 11 , ISSUE 3 ( July-September, 2017 ) > List of Articles

RESEARCH ARTICLE

Management of Abnormally Invasive Placenta: One-center Experience

Grigoriy Penzhoyan, Vladislava Novikova

Keywords : Abnormally invasive placenta,Balloon dilatation of the iliac vessels,Massive blood loss,Uterine artery embolization

Citation Information : Penzhoyan G, Novikova V. Management of Abnormally Invasive Placenta: One-center Experience. Donald School J Ultrasound Obstet Gynecol 2017; 11 (3):184-188.

DOI: 10.5005/jp-journals-10009_1521

License: CC BY-NC 4.0

Published Online: 01-03-2016

Copyright Statement:  Copyright © 2017; The Author(s).


Abstract

Aim

To present one-center experience of the management of abnormally invasive placenta (AIP).

Materials and methods

This was a retrospective cohort study of clinical cases of abnormally invasive placenta (the AIP) in Perinatal Center (PC), which is part of General Hospital— Regional Clinical Hospital N2 of Krasnodar city, in the period from 2014 to August 2016.

Results

The total number of childbirth for the period was 24 078, and AIP was diagnosed in 0.17%. The average age of women was 31.5 ± 0.8 years. About 97.5% were multiparous women and 85% women in the previous pregnancy had childbirth by cesarean section (CS): One CS—41.18%, two—32.35%, and three—23.53%. An AIP was first diagnosed in pregnancy at 11 to 39 weeks of pregnancy by ultrasound or magnetic resonance imaging (MRI). Cesarean section performed in the conditions of the X-ray operating of the endovascular department. The relative risk (RR) for accurate diagnosis of AIP by ultrasound was 1.789 ± 0.709 [95% confidence interval (CI) 0.446–7.186], and for MRI RR was 0.944 ± 0.142 (95% CI 0.715–1.246). At CS, in 85% of women balloon dilatation of the iliac vessels was performed, in 15%, uterine artery embolization (UAE), and in 72.5%, metroplasty. In 15% of women with AIP were the cause of hysterectomy without adnexa. The total blood loss was 1152.56 ± 107.67 (4,000–35,000) mL or 15.539 ± 1.7374 (5,0000–58,330) mL/kg. Maximum blood loss was in women with placenta previa and its localization in the area of the scar on the uterus that required a hysterectomy.

Conclusion

Despite increasing incidence of AIP, it is possible to prevent massive blood loss during delivery by combined treatment using radiological endovascular procedures for devascularization of the lower pelvis. Early diagnosis of placental abnormalities with regionalized approach in perinatal health makes it possible not only to preserve the women's reproductive health and fertility but also to minimize postpartum hemorrhage.

How to cite this article

Penzhoyan G, Novikova V. Management of Abnormally Invasive Placenta: One-center Experience. Donald School J Ultrasound Obstet Gynecol 2017;11(3):184-188.


PDF Share
  1. Sonographic findings of morbidly adherent placenta in the first trimester. J Ultrasound Med 2016 Feb;35(2):263-269.
  2. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 2005 May;192(5):458-461.
  3. Committee Opinion No. 529: placenta accreta. Obstet Gynecol 2012 Jul;120(1):207-211.
  4. Placenta accreta. Am J Obstet Gynecol 2010 Nov;203(5):430-439.
  5. Rising incidence of morbidly adherent placenta and its association with previous caesarean section: a 15-year analysis in a tertiary hospital in Hong Kong. Hong Kong Med J 2015 Nov;21(6):511-517.
  6. ; Sukhih, GT.; Serov, VN. et al. Obstetrics: National Guidline/Akusherstvo: Nacinalnoe rukovodstvo. M: GEHOTAR-Media; 2015.
  7. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol 2015 Mar;125(3):683-689.
  8. Pro forma for ultrasound reporting in suspected abnormally invasive placenta (AIP): an international consensus. Ultrasound Obstet Gynecol 2016 Mar;47(3):276-278.
  9. Counseling in fetal medicine: evidence-based answers to clinical questions on morbidly adherent placenta. Ultrasound Obstet Gynecol 2016 Mar;47(3):290-301.
  10. Retained placenta accreta mimicking choriocarcinoma. Case Rep Pathol 2015 Sep; 2015:167986.
  11. Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: a population-based study. J Matern Fetal Neonatal Med 2005 Sep;18(3):149-154.
  12. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births. Am J Obstet Gynecol 2013 Mar;208(3):219.e1-219.e7.
  13. Abnormally invasive placentaprevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG 2016 Jul;123(8):1348-1355.
  14. Demographic profile and high risk factors in morbidly adherent placenta. Int J Reprod Contracept Obstet Gynecol 2016 May;5(5):1617-1620.
  15. Morbidly adherent placenta: ultrasound assessment and supplemental role of magnetic resonance imaging. Semin Ultrasound CT MR 2015 Aug;36(4):324-331.
  16. The Triple-P procedure as a conservative surgical alternative to peripartum hysterectomy for placenta percreta. Int J Gynaecol Obstet 2012 May;117(2):191-194.
  17. Diagnostika, profilaktika i organosohranyayushchie metody rodorazresheniya beremennyh s vrastaniem placenty. Kazanskij Medicinskij Zhurnal 2016;97(4): 466-485.
  18. Organosberegayushchaya taktika rodorazresheniya pri istinnom prirashchenii placenty. Rossijskij Vestnik Akushera-ginekologa 2009;6:25-28.
  19. Istinnoe vrastanie placenty (placenta accreta). Konservativnaya terapiya. Akusherstvo i Ginekologiya 2011;4:118-122.
  20. Morbidly adherent placenta: interprofessional management strategies for the intrapartum period. J Perinat Neonatal Nurs 2016 Oct/Dec;30(4):319-326.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.